Methods for probing lysosomal membrane permeabilization

Cold Spring Harbor Protocols

Volumn 2015, Issue 11, 2015, Pages 975-978

  Jäättelä, Marja ^a   Nylandsted, Jesper ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; DEXTRAN ANTIBODY; PROTEINASE; DETERGENT; DIGITONIN; ENZYME; FLUORESCENT DYE;

ARTICLE; AUTOLYSIS; CANCER GROWTH; CANCER THERAPY; CELL DEATH; CELL PERMEABILIZATION; CELL VIABILITY; CELLULAR DISTRIBUTION; ELECTRON MICROSCOPY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LYSOSOME MEMBRANE; NECROSIS; PROTEIN EXPRESSION; CELL LINE; DRUG EFFECTS; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; LYSOSOME; MEMBRANE; METABOLISM; PERMEABILITY; PHYSIOLOGY; PROCEDURES;

CELL LINE; DETERGENTS; DIGITONIN; ENZYMES; FLUORESCENT DYES; HUMANS; IMMUNOHISTOCHEMISTRY; LYSOSOMES; MEMBRANES; PERMEABILITY;

EID: 84946014232     PISSN: 19403402     EISSN: 15596095     Source Type: Journal    
DOI: 10.1101/pdb.top070367     Document Type: Article

References (35)

1. Aits S, Jäättelä M, Nylandsted J. 2015. Methods for the quantification of lysosomal membrane permeabilization: A hallmark of lysosomal cell death. In Lysosomes and Lysosomal Diseases (ed Platt F, Platt N), pp. 261–286. Academic Press, Waltham.
2. Bitensky L. 1963. Modifications to the Gomori acid phosphatase technique for controlled temperature frozen sections. Q J Micr Sci 104: 193–196.
3. Boya P, Kroemer G. 2008. Lysosomal membrane permeabilization in cell death. Oncogene 27: 6434–6451.
4. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. 2003. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197: 1323–1334.
5. Brunk UT, Dalen H, Roberg K, Hellquist HB. 1997. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic Biol Med 23: 616–626.
6. Brunk UT, Neuzil J, Eaton JW. 2001. Lysosomal involvement in apoptosis. Redox Rep 6: 91–97.
7. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, Salvesen GS, Turk B. 2004. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279: 3578–3587.
8. de Duve C. 1983. Lysosomes revisited. Eur J Biochem 137: 391–397.
9. de Duve C, Pressman BC, Gianetto R, Wattiaux R, Appelmans F. 1955. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J 60: 604–617.
10. Ellegaard A-M, Jäättelä M, Nylandsted J. 2015. Visualizing lysosomal membrane permeabilization by fluorescent dextran release. Cold Spring Harb Protoc doi: 10.1101/pdb.prot086173.
11. Fehrenbacher N, Gyrd-Hansen M, Poulsen B, Felbor U, Kallunki T, Boes M, Weber E, Leist M, Jäättelä M. 2004. Sensitization to the lysosomal cell death pathway upon immortalization and transformation. Cancer Res 64: 5301–5310.
12. Firestone RA, Pisano JM, Bonney RJ. 1979. Lysosomotropic agents. 1. Synthesis and cytotoxic action of lysosomotropic detergents. J Med Chem 22: 1130–1133.
13. Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, Jäättelä M. 2001. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153: 999–1010.
14. Gerasimenko JV, Gerasimenko OV, Petersen OH. 2001. Membrane repair: Ca(2+)-elicited lysosomal exocytosis. Curr Biol 11: R971–R974.
15. Groth-Pedersen L, Jäättelä M, Nylandsted J. 2015. A method to monitor lysosomal membrane permeabilization by immunocytochemistry. Cold Spring Harb Protoc doi: 10.1101/pdb.prot086181.
16. Jäättelä M, Nylandsted J. 2015. Quantification of lysosomal membrane permeabilization by cytosolic cathepsin and β-N-acetyl-glucosaminidase activity measurements. Cold Spring Harb Protoc doi: 10.1101/pdb.prot086165.
17. Kagedal K, Zhao M, Svensson I, Brunk UT. 2001. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359: 335–343.
18. Kallunki T, Olsen OD, Jäättelä M. 2013. Cancer-associated lysosomal changes: Friends or foes. Oncogene 32: 1995–2004.
19. Kirkegaard T, Jäättelä M. 2009. Lysosomal involvement in cell death and cancer. Biochim Biophys Acta 1793: 746–754.
20. Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I, Zylicz A, Knudsen J, Sandhoff K, Arenz C, et al. 2010. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology. Nature 463: 549–553.
21. Kolter T, Sandhoff K. 2010. Lysosomal degradation of membrane lipids. FEBS Lett 584: 1700–1712.
22. Kreuzaler PA, Staniszewska AD, Li W, Omidvar N, Kedjouar B, Turkson J, Poli V, Flavell RA, Clarkson RW, Watson CJ. 2011. Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol 13: 303–309.
23. Kroemer G, Jäättelä M. 2005. Lysosomes and autophagy in cell death control. Nat Rev Cancer 5: 886–897.
24. Kurz T, Eaton JW, Brunk UT. 2011. The role of lysosomes in iron metabolism and recycling. Int J Biochem Cell Biol 43: 1686–1697.
25. Link G, Pinson A, Hershko C. 1993. Iron loading of cultured cardiac myocytes modifies sarcolemmal structure and increases lysosomal fragility. J Lab Clin Med 121: 127–134.
26. Moin K, Cao L, Day NA, Koblinski JE, Sloane BF. 1998. Tumor cell membrane cathepsin B. Biol Chem 379: 1093–1099.
27. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, Weber E, Multhoff G, Rohde M, Jäättelä M. 2004. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 200: 425–435.
28. Palermo C, Joyce JA. 2008. Cysteine cathepsin proteases as pharmacological targets in cancer. Trends Pharmacol Sci 29: 22–28.
29. Pryor PR, Luzio JP. 2009. Delivery of endocytosed membrane proteins to the lysosome. Biochim Biophys Acta 1793: 615–624.
30. Saftig P, Klumperman J. 2009. Lysosome biogenesis and lysosomalmembrane proteins: Trafficking meets function. Nat Rev Mol Cell Biol 10: 623–635.
31. Schotte P, Declercq W, Van Huffel S, Vandenabeele P, Beyaert R. 1999. Nonspecific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett 442: 117–121.
32. Silverman GA, Bartuski AJ, Cataltepe S, Gornstein ER, Kamachi Y, Schick C, Uemura Y. 1998. SCCA1 and SCCA2 are proteinase inhibitors that map to the serpin cluster at 18q21.3. Tumour Biol 19: 480–487.
33. Stoka V, Turk V, Turk B. 2007. Lysosomal cysteine cathepsins: Signaling pathways in apoptosis. Biol Chem 388: 555–560.
34. Suminami Y, Nawata S, Kato H. 1998. Biological role of SCC antigen. Tumour Biol 19: 488–493.
35. Vasiljeva O, Turk B. 2008. Dual contrasting roles of cysteine cathepsins in cancer progression: Apoptosis versus tumour invasion. Biochimie 90: 380–386.